Literature DB >> 17878345

T regulatory cells control numbers of NK cells and CD8alpha+ immature dendritic cells in the lymph node paracortex.

Martin Giroux1, Ekaterina Yurchenko, Jessica St-Pierre, Ciriaco A Piccirillo, Claude Perreault.   

Abstract

The spleen contains numerous NK cells whose differentiation profile is characterized by a preponderance of mature elements located mainly in the red pulp. In contrast, lymph nodes (LNs) contain few NK cells and they are sited mostly in T cell zones and skewed toward immature developmental stages. We show that, in mice, naturally occurring CD4+ Foxp3+ regulatory T (Treg) cells are both necessary and sufficient to repress accumulation of NK cells in resting LNs. Moreover, we present evidence that Treg cells hamper generation of mature NK cells through short-range interactions with NK precursors. In turn, mature NK cells specifically regulate the amount of CD8alpha+ phenotypically immature dendritic cells present in LN T cell zones. We propose that the dominant influence of Treg cells on NK cell precursors and CD8alpha+ immature dendritic cells explains why "quiescent" LNs in the absence of infection function as privileged sites for induction and maintenance of tolerance to peripheral Ags.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17878345     DOI: 10.4049/jimmunol.179.7.4492

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells.

Authors:  Purevdorj B Olkhanud; Dolgor Baatar; Monica Bodogai; Fran Hakim; Ronald Gress; Robin L Anderson; Jie Deng; Mai Xu; Susanne Briest; Arya Biragyn
Journal:  Cancer Res       Date:  2009-06-30       Impact factor: 12.701

2.  Deletion of Fanca or Fancd2 dysregulates Treg in mice.

Authors:  Wei Du; Ozlem Erden; Andrew Wilson; Jared M Sipple; Jonathan Schick; Parinda Mehta; Kasiani C Myers; Kris A Steinbrecher; Stella M Davies; Qishen Pang
Journal:  Blood       Date:  2014-02-05       Impact factor: 22.113

3.  Thymus-derived regulatory T cells restrain pro-inflammatory Th1 responses by downregulating CD70 on dendritic cells.

Authors:  Maxime Dhainaut; Caroline Coquerelle; Sophie Uzureau; Julie Denoeud; Valérie Acolty; Guillaume Oldenhove; Adrien Galuppo; Tim Sparwasser; Kris Thielemans; Etienne Pays; Hideo Yagita; Jannie Borst; Muriel Moser
Journal:  EMBO J       Date:  2015-03-18       Impact factor: 11.598

Review 4.  Adaptive control of innate immunity.

Authors:  Anil Shanker
Journal:  Immunol Lett       Date:  2010-04-13       Impact factor: 3.685

5.  Altered natural killer (NK) cell frequency and phenotype in latent autoimmune diabetes in adults (LADA) prior to insulin deficiency.

Authors:  C Akesson; K Uvebrant; C Oderup; K Lynch; R A Harris; A Lernmark; C-D Agardh; C M Cilio
Journal:  Clin Exp Immunol       Date:  2010-04-09       Impact factor: 4.330

Review 6.  Neoplastic "Black Ops": cancer's subversive tactics in overcoming host defenses.

Authors:  Arya Biragyn; Dan L Longo
Journal:  Semin Cancer Biol       Date:  2012-01-12       Impact factor: 15.707

7.  CD40-activated B cells are more potent than immature dendritic cells to induce and expand CD4(+) regulatory T cells.

Authors:  Jian Zheng; Yinping Liu; Yu-Lung Lau; Wenwei Tu
Journal:  Cell Mol Immunol       Date:  2010-01       Impact factor: 11.530

8.  Cancer-produced metabolites of 5-lipoxygenase induce tumor-evoked regulatory B cells via peroxisome proliferator-activated receptor α.

Authors:  Katarzyna Wejksza; Catalina Lee-Chang; Monica Bodogai; Jessica Bonzo; Frank J Gonzalez; Elin Lehrmann; Kevin Becker; Arya Biragyn
Journal:  J Immunol       Date:  2013-02-13       Impact factor: 5.422

Review 9.  Surveillance of antigen-presenting cells by CD4+ CD25+ regulatory T cells in autoimmunity: immunopathogenesis and therapeutic implications.

Authors:  Sébastien André; David F Tough; Sébastien Lacroix-Desmazes; Srini V Kaveri; Jagadeesh Bayry
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

10.  [Regulatory T cells and NK cells in cancer patients].

Authors:  C Bergmann
Journal:  HNO       Date:  2014-06       Impact factor: 1.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.